Genscript Biotech Corpora... (GNNSF)
PNK: GNNSF
· Real-Time Price · USD
1.30
0.00 (0.00%)
At close: Apr 28, 2025, 8:00 PM
0.00% (1D)
| Bid | 1.24 |
| Market Cap | 2.78B |
| Revenue (ttm) | 1.01B |
| Net Income (ttm) | -177.01M |
| EPS (ttm) | -0.08 |
| PE Ratio (ttm) | -16.25 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.49 |
| Volume | 750 |
| Avg. Volume (20D) | 545 |
| Open | 1.30 |
| Previous Close | 1.30 |
| Day's Range | 1.30 - 1.30 |
| 52-Week Range | 1.05 - 1.90 |
| Beta | 1.02 |
About GNNSF
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. It operates through four segments: Life Science Services and Products, Biologics Development Services, Industrial Synthetic Biology Products, and Cell Therapy. The Life Science Services a...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 28, 2017
Employees 5,568
Stock Exchange PNK
Ticker Symbol GNNSF
Website https://www.genscript.com